MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Three Arch Partners-CCF
*Portfolio Companies: Three Arch
Visiogen, Inc.
Parents
*Architects: Ophthalmology, Optometry & Ocular Health (Health IT, Devices & Technology)
*Portfolio Companies: Foundation Medical
*Portfolio Companies: Three Arch
Companies: Acquired_(M&A)
Finance & Acquisitions: Abbott
Children
2009: Abbott Labs to acquire Visiogen for $400 million (2009)
Intraocular lenses are implanted in a patient's eye after the removal of the natural lens that has become clouded by a cataract.
It is designed to mimic the eye's natural ability to change focus (accommodation), delivering improved vision at all distances, potentially eliminating the need for glasses or contact lenses, reducing glare and nighttime halos, and improving contrast sensi
Next-generation intraocular lenses, or devices used to treat cataract patients
Products for cataract surgery and other ophthalmologic markets.
Visiogen's Synchrony® accommodating IOL is a significant advancement in artificial lens technology.